AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | 5,367.00 | 4,976.00 | 6,246.00 | 6,345.00 | 6,267.00 | 3,549.00 | 7,535.00 | 7,041.00 | 9,960.00 | 13,427.00 | 13,324.00 | 17,588.00 | 22,777.00 | 24,943.00 | 22,839.00 | |
| Operating Cash (Net) | 5,367.00 | 4,976.00 | 6,246.00 | 6,345.00 | 6,267.00 | 3,549.00 | 7,535.00 | 7,041.00 | 9,960.00 | 13,427.00 | 13,324.00 | 17,588.00 | 22,777.00 | 24,943.00 | 22,839.00 | |
| Accounts Receivable | -322.00 | -60.00 | -497.00 | 223.00 | -9,829.00 | -5,080.00 | -5,985.00 | -71.00 | -391.00 | -591.00 | -74.00 | -929.00 | -1,321.00 | -1,455.00 | 66.00 | |
| Accounts Payable | 210.00 | -695.00 | 1,497.00 | -731.00 | -426.00 | -193.00 | 1,503.00 | -1,187.00 | 425.00 | 190.00 | -1,121.00 | 1,514.00 | 1,628.00 | 1,605.00 | 3,840.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | 503.00 | -866.00 | 706.00 | -621.00 | 658.00 | -788.00 | 504.00 | -1,689.00 | 9.00 | -1,126.00 | -1,329.00 | 106.00 | -1,322.00 | -258.00 | 2,813.00 | |
| Other WC | 450.00 | -38.00 | -205.00 | 90.00 | 10,969.00 | 4,688.00 | 5,420.00 | -393.00 | -118.00 | -499.00 | 97.00 | -439.00 | -1,487.00 | 278.00 | -676.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | -486.00 | -5,031.00 | 553.00 | -2,418.00 | 879.00 | -926.00 | -12,936.00 | -6,074.00 | -274.00 | -1,006.00 | 596.00 | -37,557.00 | -2,344.00 | -623.00 | -2,009.00 | |
| Capital Expenditure | -312.00 | -448.00 | -355.00 | -333.00 | -491.00 | -612.00 | -532.00 | -479.00 | -529.00 | -638.00 | -552.00 | -798.00 | -787.00 | -695.00 | -777.00 | |
| Purchases of Investments | -4.00 | -93.00 | -1,943.00 | -2,550.00 | -930.00 | -1,169.00 | -851.00 | -5,315.00 | -2,230.00 | -1,792.00 | -583.00 | -61.00 | -119.00 | -1,438.00 | -77.00 | |
| Sale/Maturity of Investment | - - | 1.00 | 1,254.00 | 1,153.00 | 2,705.00 | 1,477.00 | 880.00 | 2,359.00 | 2,793.00 | 2,160.00 | 2,699.00 | 1,525.00 | 98.00 | 1,530.00 | 55.00 | |
| Property, Plant, Equipment (P&PE) | -312.00 | -448.00 | -355.00 | -333.00 | -491.00 | -612.00 | -532.00 | -479.00 | -529.00 | -638.00 | -552.00 | -798.00 | -787.00 | -695.00 | -777.00 | |
| Acquisitions (Net) | -170.00 | -2,621.00 | -272.00 | -688.00 | -405.00 | -622.00 | -12,452.00 | -2,757.00 | -308.00 | -736.00 | -1,135.00 | -39,610.00 | -1,902.00 | -794.00 | -1,223.00 | |
| Other Investing Activities | - - | -1,870.00 | 1,870.00 | -2,085.00 | 1,775.00 | 308.00 | 19.00 | 118.00 | -308.00 | -736.00 | 167.00 | 1,387.00 | 366.00 | 774.00 | 13.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -4,881.00 | -65.00 | -6,783.00 | -1,931.00 | -3,442.00 | -3,293.00 | -5,752.00 | -3,928.00 | -5,512.00 | -14,396.00 | -18,708.00 | -11,501.00 | -19,039.00 | -24,803.00 | -17,222.00 | |
| Debt Repayment | -34.00 | - - | -21.00 | - - | - - | -17.00 | -4,018.00 | -6,010.00 | -25.00 | -6,035.00 | -5,235.00 | -5,683.00 | -9,414.00 | -14,433.00 | -4,149.00 | |
| Dividends Paid | - - | - - | - - | - - | -2,555.00 | -2,661.00 | -3,294.00 | -3,717.00 | -4,107.00 | -5,580.00 | -6,366.00 | -7,716.00 | -9,261.00 | -10,043.00 | -10,539.00 | |
|
Common Stock
|
- - | - - | - - | - - | 320 | 652 | 28,350 | 17,899 | 1,410 | 21,351 | 32,119 | 4,187 | 2,178 | 1,749 | 2,152 | |
| Issued | - - | - - | - - | - - | - - | - - | 20,783.00 | 11,866.00 | - - | 9,337.00 | 31,490.00 | 3,209.00 | 1,244.00 | 262.00 | 180.00 | |
| Repurchased | - - | - - | - - | - - | -320.00 | -652.00 | -7,567.00 | -6,033.00 | -1,410.00 | -12,014.00 | -629.00 | -978.00 | -934.00 | -1,487.00 | -1,972.00 | |
| Other Financing Activities | -4,846.00 | 65.00 | -6,761.00 | 1,931.00 | -567.00 | 20.00 | -152.00 | -34.00 | 30.00 | -104.00 | -552.00 | -333.00 | -674.00 | 898.00 | -742.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | - - | -55.00 | 9.00 | 27.00 | 5,901.00 | 9,595.00 | 8,348.00 | 8,399.00 | 5,100.00 | 9,303.00 | 7,289.00 | 39,924.00 | 8,449.00 | 9,746.00 | 9,201.00 | |
| End of Period | - - | 10.00 | 27.00 | 5,901.00 | 9,595.00 | 8,348.00 | 8,399.00 | 5,100.00 | 9,303.00 | 7,289.00 | 39,924.00 | 8,449.00 | 9,746.00 | 9,201.00 | 12,814.00 | |
| Change | - - | 65.00 | 17.00 | 5,874.00 | 3,694.00 | -1,247.00 | 51.00 | -3,299.00 | 4,203.00 | -2,014.00 | 32,635.00 | -31,475.00 | 1,297.00 | -545.00 | 3,613.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 697.00 | 1,184.00 | 1,272.00 | 1,150.00 | 897.00 | 786.00 | 836.00 | 1,189.00 | 1,501.00 | 1,765.00 | 2,017.00 | 6,471.00 | 8,521.00 | 8,467.00 | 8,698.00 | |
| Stock Based Compensation | 156.00 | 167.00 | 162.00 | 187.00 | 212.00 | 241.00 | 282.00 | 353.00 | 365.00 | 421.00 | 430.00 | 753.00 | 692.00 | 671.00 | 747.00 | |
| Other | -627.00 | 313.00 | 672.00 | 354.00 | 372.00 | 1,536.00 | 769.00 | 937.00 | 1,534.00 | 6,256.00 | 3,624.00 | 7,961.00 | 4,235.00 | 6,149.00 | 8,587.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | 5,054.00 | 4,528.00 | 5,891.00 | 6,012.00 | 5,776.00 | 2,937.00 | 7,003.00 | 6,562.00 | 9,431.00 | 12,789.00 | 12,772.00 | 16,790.00 | 21,990.00 | 24,248.00 | 22,062.00 | |
| Cash Conversion Cycle (CCC) | - - | 119.00 | 115.00 | 128.00 | 110.00 | 98.00 | 85.00 | 70.00 | 72.00 | 62.00 | 77.00 | 94.00 | 69.00 | 84.00 | 92.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | 55.00 | - - | 16.00 | -10.00 | -577.00 | -300.00 | -338.00 | 29.00 | -39.00 | 7.00 | -5.00 | -97.00 | -62.00 | 5.00 |